Patent Yard Sign in
Expired European patentEurope

Human polymorphic epithelial mucin polypeptides for use in therapy and diagnosis

EP 0341252 B1 · Applicant: IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed January 7, 1988 and granted November 19, 1997. A European patent lasts at most 20 years from filing, so its term ended January 7, 2008.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by July 7, 2013.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledJanuary 7, 1988
PublishedNovember 15, 1989
GrantedNovember 19, 1997
Term endedJanuary 7, 2008
Application numberEP 88900775
Classification (CPC)C07K16/30 +2 more

Timeline

Timeline From EPO dates

1989199119931995199719992001200320052007Application filedJan 7, 1988PublishedNov 15, 1989Patent grantedNov 19, 1997Term endedJan 7, 2008

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.